Evidence map›Paper›PMID 27671461›Full record

ArticleEpidemiology and infection2017

Hepatitis E in Norway: seroprevalence in humans and swine.

H Lange, J Øverbø, K Borgen, S Dudman, G Hoddevik, A M Urdahl, L Vold, S K Sjurseth

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prevalence ofOne health (Amsterdam, Netherlands) · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Transmission of Hepatitis E Virus.Advances in experimental medicine and biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

H LangeNorwegian Institute of Public Health,Department of Infectious Disease Epidemiology,Oslo,Norway.
J ØverbøNorwegian Institute of Public Health,Department of Virology,Oslo,Norway.
K BorgenNorwegian Institute of Public Health,Department of Infectious Disease Epidemiology,Oslo,Norway.
S DudmanNorwegian Institute of Public Health,Department of Virology,Oslo,Norway.
G HoddevikNorwegian Institute of Public Health,Department of Virology,Oslo,Norway.
A M UrdahlNorwegian Veterinary Institute,Oslo,Norway.
L VoldNorwegian Institute of Public Health,Department of Infectious Disease Epidemiology,Oslo,Norway.
S K SjursethNorwegian Veterinary Institute,Oslo,Norway.
Norwegian Institute of Public Health · NONorwegian Veterinary Institute · NOEuropean Centre for Disease Prevention and Control · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Norway, no published data on seroprevalence of hepatitis E virus (HEV) in humans and swine exists. Serum samples from blood donors, veterinarians, swine farm workers and swine were analysed by ELISA to estimate the seroprevalence of HEV in Norway and to investigate the association between direct contact with swine and HEV seroprevalence in humans. The seroprevalence of HEV IgG antibodies was 30% (24/79) in farm workers, 13% (21/163) in veterinarians, 14% (162/1200) in blood donors and 90% (137/153) in swine. Our results show a high seroprevalence of HEV in humans and swine in Norway. HEV seroprevalence in farm workers and blood donors increased with age, and veterinarians working with swine were twice as likely to be HEV seropositive compared to other veterinarians. High HEV seroprevalence in farm workers and veterinarians working with swine support previous reports suggesting swine as a reservoir for HEV infections in humans in Europe.

Indexed as

AdultAgedAged, 80 and overAnimalsEnzyme-Linked Immunosorbent AssayFemaleHepatitis AntibodiesHepatitis EHumansImmunoglobulin GMaleMiddle AgedNorwayOccupational ExposureSeroepidemiologic StudiesSurveys and QuestionnairesHepatitis AntibodiesImmunoglobulin GEstimatinghepatitis Eprevalence of diseaseserologyzoonoses

Identifiers

PMID27671461
PMCPMC9507337
OpenAlexW2524079072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.